SRTS Sensus Healthcare
- 3.410
- +0.080+2.40%
- 3.470
- +0.060+1.76%
Sensus Healthcare News
Sensus Healthcare Issues Reminder That Its First Quarter 2024 Financial Results and Business Update Conference Call Will Be Held on Thursday, May 9, 2024
BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
Navigating Uncertainty: How Global Crises Threaten Sensus Healthcare's Growth and Operations
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces management will participate in one-on-one or small group meetings with institutional investors at the 36th Annual Roth conference to be held March 17th – 19th in Dana Point, Calif.
Sensus Healthcare Launches "Fair Deal Agreement" for Its SRT-100 Vision at the American Academy of Dermatology Annual Meeting
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces the successful launch of its new "Fair Deal Agreement" for the SRT-100 Vision (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego.
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for
T2 Biosystems, AMN Healthcare Services Among Healthcare Movers
Sensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call Transcript
Analysts Are Bullish on Top Healthcare Stocks: Foghorn Therapeutics (FHTX), Sensus Healthcare (SRTS)
Earnings Call Summary | Sensus Healthcare(SRTS.US) Q4 2023 Earnings Conference
The following is a summary of the Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript:Financial Performance:Sensus Healthcare saw a decline in Q4 revenues for 2023, reporting $12.6 million
Sensus Healthcare GAAP EPS of $0.26 Beats by $0.12, Revenue of $12.6M Beats by $0.54M
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, Vs. Street Est of $12.1M
04:08 PM EST, 02/08/2024 (MT Newswires) -- Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M
Sensus Healthcare 4Q EPS 26c >SRTS
Sensus Healthcare 4Q EPS 26c >SRTS
Press Release: Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results -- Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to m
Sensus Healthcare Announces U.S. Patent for SRT-100 Vision System
Sensus Healthcare Issued U.S. Patent No. 11,894,123 B2, Titled "Radiotherapy Mobile and Wireless Device Workflow Management System."
Sensus Healthcare Issued U.S. Patent No. 11,894,123 B2, Titled "Radiotherapy Mobile and Wireless Device Workflow Management System."
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. • ArcelorMittal (NYSE:MT) is estimated to r
Earnings Preview For Sensus Healthcare
Sensus Healthcare (NASDAQ:SRTS) is set to give its latest quarterly earnings report on Thursday, 2024-02-08. Here's what investors need to know before the announcement.Analysts estimate that Sensus He
Analysis
Price Target
No Data
